| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/16/2005 | EP1513862A2 Novel derivatives of androstane and androstene with ascorbic acid and use thereof in treating or preventing various conditions, diseases, and disorders |
| 03/16/2005 | EP1513859A2 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 03/16/2005 | EP1513842A1 Substituted hexahydropyrrolo (1,2-a)pyrazines, octahydropyrido(1,2-a)pyrazines and decahydropyrazino(1,2-a)azepines |
| 03/16/2005 | EP1513839A1 3-substituted quinuclidines and their use |
| 03/16/2005 | EP1513837A1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 03/16/2005 | EP1513836A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 03/16/2005 | EP1513835A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 03/16/2005 | EP1513834A1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
| 03/16/2005 | EP1513833A1 Novel 3-(4-oxo-4h-chromen-2-yl)-(1h)-quinoline-4-one derivatives, method for preparing same and pharmaceutical compositions containing same |
| 03/16/2005 | EP1513830A1 Bisindolyl-maleimid derivatives as kinase inhibitors |
| 03/16/2005 | EP1513827A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors |
| 03/16/2005 | EP1513821A1 Protein kinase inhibitors |
| 03/16/2005 | EP1513820A2 Compounds, compositions, and methods |
| 03/16/2005 | EP1513818A2 Heterocyclic inhibitors of kinases |
| 03/16/2005 | EP1513810A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans |
| 03/16/2005 | EP1513589A1 1,5-disubstituted pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma |
| 03/16/2005 | EP1513588A2 Use of new etonogestrel esters |
| 03/16/2005 | EP1513560A2 Method of magnetically manipulating a cell with magnetisable particles |
| 03/16/2005 | EP1513557A2 Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseases |
| 03/16/2005 | EP1513551A1 Vaccination with immuno-isolated cells producing an immunomodulator |
| 03/16/2005 | EP1513549A2 Human prolactin antagonist-angiogenesis inhibitor fusion proteins |
| 03/16/2005 | EP1513546A1 Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone |
| 03/16/2005 | EP1513536A1 Use of compounds that stimulate cgmp |
| 03/16/2005 | EP1513531A1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 03/16/2005 | EP1513529A1 Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 03/16/2005 | EP1513524A2 Ether substituted imidazopyridines |
| 03/16/2005 | EP1513522A2 Methods of treating conditions associated with an edg receptor |
| 03/16/2005 | EP1513520A2 Substituted pyrrolines as kinase inhibitors |
| 03/16/2005 | EP1513516A1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS ANDPROCESSES FOR PREPARING AND THEIR USES |
| 03/16/2005 | EP1513506A1 Targeting system comprising uniformly-sized nanoparticles with at least one polymer and at least one positively-charged polysaccharide and preparation method thereof |
| 03/16/2005 | EP1513419A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 03/16/2005 | EP1453510A4 Neurotransmitter balance chemotherapy |
| 03/16/2005 | EP1355903B1 Pyrazole derivatives against tgf overexpression |
| 03/16/2005 | EP1353693B1 Pharmaceutical combination containing a 4-quinazolineamine and paclitaxel, carboplatin or vinorelbine for the treatment of cancer |
| 03/16/2005 | EP1351962B1 Thienopyrimidine |
| 03/16/2005 | EP1311476B1 Aza-amino acid derivatives (factor x a?-inhibitors 15) |
| 03/16/2005 | EP1268784B1 Genes involved in intestinal inflammatory diseases and use thereof |
| 03/16/2005 | EP1233959B1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 03/16/2005 | EP1226119B1 Tyrosine kinase inhibitors |
| 03/16/2005 | EP1204423B1 Therapeutic antibody against muc-1 antigen and methods for their use |
| 03/16/2005 | EP1171143B9 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same |
| 03/16/2005 | EP1165134B1 Use of anti-ferritin monoclonal antibodies in the treatment of some cancers |
| 03/16/2005 | EP1146873B1 Anti-androgens and methods for treating disease |
| 03/16/2005 | EP1140900B1 Pyrazole compounds and uses thereof |
| 03/16/2005 | EP1117296B1 Combination of bisphosphonate and tetracycline |
| 03/16/2005 | EP1049664B1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
| 03/16/2005 | EP0929553B1 Pyrimidine derivatives and processes for the preparation thereof |
| 03/16/2005 | EP0907737B1 Il-6 mutein |
| 03/16/2005 | CN1596371A Novel self-assembly molecules |
| 03/16/2005 | CN1596314A Method of determining a chemotherapeutic regimen based on ercc1 and ts expression |
| 03/16/2005 | CN1596313A Humanized collagen antibodies and related methods |
| 03/16/2005 | CN1596311A Mammalian cell-infecting virus vector encoding epitope-bound beta2m and utilization thereof |
| 03/16/2005 | CN1596266A Specific binding agents of human angiopoietin-2 |
| 03/16/2005 | CN1596259A Crystals of taxane derivative and process for their production |
| 03/16/2005 | CN1596257A Novel crystalline compound |
| 03/16/2005 | CN1596255A Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 03/16/2005 | CN1596251A Piperazine derivatives having SST1 antagonistic activity |
| 03/16/2005 | CN1596250A Paclitaxel solvates |
| 03/16/2005 | CN1596249A Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them |
| 03/16/2005 | CN1596141A Conjugated anti-psychotic drugs and uses thereof |
| 03/16/2005 | CN1596129A Water-soluble antibiotic comprising an amino sugar, in the form of a polysaccharide conjugate |
| 03/16/2005 | CN1596127A Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 03/16/2005 | CN1596123A Interferon therapeutic effect-potentiating agents |
| 03/16/2005 | CN1596118A Therapeutical treatments |
| 03/16/2005 | CN1596116A Anticancer compositions |
| 03/16/2005 | CN1596115A Treatment of hyperproliferative diseases using active vitamin D analogues |
| 03/16/2005 | CN1596114A Substituted 1, 4-benzodiazepines and uses thereof for the treatment of cancer |
| 03/16/2005 | CN1596111A Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| 03/16/2005 | CN1596109A Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
| 03/16/2005 | CN1594587A Preparation for fungus extracellular polysaccharide compound and application thereof |
| 03/16/2005 | CN1594580A New genetic engineering drug for multi-target inhibiting growth of tumor |
| 03/16/2005 | CN1594358A Method for reducing or inhibition of proliferation of oncogenic cells and compound used in it (variants) |
| 03/16/2005 | CN1594354A Oleanolic acid couple derivatives and their pharmaceutical use |
| 03/16/2005 | CN1594347A Gene therapeutic drug hdm2-siRNA for breast cancer |
| 03/16/2005 | CN1594341A Fatty acid ester compounds of ginsenoside secondary glycoside compound K and method for preparing same |
| 03/16/2005 | CN1594340A Process for extraction refining amygdalin |
| 03/16/2005 | CN1594318A Linked piperidine hydroxycamptothecin, its salts and its salts (0-10) hydrate, and preparation and preparing process thereof |
| 03/16/2005 | CN1594311A Novel spiro compound bulbophyllispiradienone having activities of anti-cancer and inhibiting NO release and its derivatives |
| 03/16/2005 | CN1594309A Diphenoxybenzyl compounds having activities of anti-cancer and inhibiting macrophage from releasing NO |
| 03/16/2005 | CN1594297A Process for synthesis of lonidamine |
| 03/16/2005 | CN1594267A Diterpenoid monomer and its preparation method and application for preparing anti-cancer drugs |
| 03/16/2005 | CN1594247A Yew genus plant extract and its extraction method and application |
| 03/16/2005 | CN1593665A Method for preparing radioactive nuclide magnetic microsphere used in vivo |
| 03/16/2005 | CN1593664A Combined guided medicament for treating nasopharyngeal carcinoma and preparation method thereof |
| 03/16/2005 | CN1593645A Anticancer medicine and its preparation |
| 03/16/2005 | CN1593620A Detoxification Chinese medicine |
| 03/16/2005 | CN1593597A Dampness dispersing, cancer resisting medicine, its preparation method and its application in the process for preparing anticancer medicine |
| 03/16/2005 | CN1593550A Antineoplastic vascular embolic agent and its preparing process |
| 03/16/2005 | CN1593523A Chinese traditional medicinal capsule for treating primary liver cancer and its preparing process |
| 03/16/2005 | CN1593522A Chinese traditional medicinal powder for treating primary liver cancer and its preparing process |
| 03/16/2005 | CN1593521A Chinese traditional medicinal effervescence tablet for treating primary liver cancer and its preparing process |
| 03/16/2005 | CN1593512A A blood lowering botanical extract and its preparation and preparing process |
| 03/16/2005 | CN1593502A Snake slough pills and its prescription |
| 03/16/2005 | CN1593495A Compound medicine for treating cancer and preparing process thereof |
| 03/16/2005 | CN1593494A Medicine for treating tumor and its preparation process |
| 03/16/2005 | CN1593493A Therapy assisting agent and its preparation |
| 03/16/2005 | CN1593483A Medicine for treating leukopenia and its preparing process |
| 03/16/2005 | CN1593480A Fig buccal tablet and its preparing process |
| 03/16/2005 | CN1593476A Cell differentiation inducer |
| 03/16/2005 | CN1593467A Method for extracting medicinal and edible substance from dictyoptera |